SCD-212

N/A

Report date: 2023/01/01 12:03:47

Base Information

Drug NameSCD-212
Drug Alias NameSCD-212
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSam Chun Dang Pharm Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A